Effect of Kefir on Symptom Management and Quality of Life in Oncology

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

August 21, 2023

Study Completion Date

February 1, 2024

Conditions
Breast CancerColorectal Cancer
Interventions
OTHER

kefir consumption

Support and information was received from the Food Technology Department of a university's Experimental Medicine Application and Research Center. It was decided to choose the kefir to be used, which is produced from pasteurized cow's milk, lactase enzyme, probiotic culture (B. Lactis) and kefir culture, will meet the B12 need, contribute to increasing vitality and energy, and has the most suitable content in the market. Kefir, supplied by the researcher, was given to the patients at the end of each session in the amount that the patients should consume for a week, following the cold chain rule. While consuming kefir, it was recommended to gargle it in the mouth, hold it for a while, and then swallow. Patients were contacted for a week after the session to ensure that they applied kefir correctly.

Trial Locations (1)

35100

Health Sciences University Izmir Tepecik Training and Research Hospital, Bornova Oncology Hospital, Additional Service Building, Izmir

All Listed Sponsors
lead

Izmir Bakircay University

OTHER

NCT06517420 - Effect of Kefir on Symptom Management and Quality of Life in Oncology | Biotech Hunter | Biotech Hunter